8-K ·Filed Sep 23, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
This is a routine investor relations disclosure with no financial data or guidance. Monitor for future pipeline updates or clinical trial results to assess platform impact.
Latest settled — T+20d ⚠ clustered
LTRN ▼ -47.02% at T+20d
NEUTRAL call -47.02% · α vs SPY -46.61% · entry $1.21 → $0.6410
Latest observation: T+21 -21.70% FF3 residual α
T+1d
+0.83%
call +0.83% · α +0.28%
$1.22
settled 5w ago
T+5d
-17.36%
call -17.36% · α -16.94%
$1.00
settled 27d ago
T+20d
-47.02%
call -47.02% · α -46.61%
$0.6410
settled 6d ago
T+60d
Pending
in 7w
Price Chart
Loading chart...
Executive Summary
Lantern Pharma filed an 8-K to disclose a live webinar held on September 23, 2026, discussing its Open-Medicine AI multi-agentic platform for drug development. The filing includes a replay link and a furnished presentation (Exhibit 99.1). No material financial data, guidance, or operational updates were provided.
Key Facts
- Lantern Pharma hosted a live webinar on September 23, 2026, discussing the Open-Medicine AI multi-agentic platform for drug development.
- A replay of the webinar is available at https://youtu.be/s7br8vjMk4s and on the company's website.
- A copy of the presentation used during the webinar was furnished as Exhibit 99.1 to the 8-K.
- The information is furnished under Item 7.01 and is not deemed 'filed' for SEC liability purposes.
Financial Impact
No financial figures disclosed in the filing.
Risk Factors
- No material financial or operational information was provided, limiting actionable trading signals.
- The AI platform discussion is promotional in nature and may not translate to near-term value creation.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-044007 |
| Document: 0001493152-26-044007-index-headers.html | 0001493152-26-044007 |
| Document: 0001493152-26-044007-index.html | 0001493152-26-044007 |
| Document: 0001493152-26-044007.txt | 0001493152-26-044007 |
15 reports for LTRN
60% Hit rate @ T+60 Went positive at some point 6 of 9 best @ T+60▲ +56.19%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | DEF 14A | $0.6564 | awaiting T+60 | — | $0.6151 (+6.29%) |
Oct 13, 2026 13d ago | SC 13G/A | $0.7107 | awaiting T+60 | — | $0.6151 (−13.45%) |
Oct 1, 2026 25d ago | 8-K | $0.8601 | awaiting T+60 | — | $0.6151 (+28.49%) |
Sep 30, 2026 26d ago | 8-K | $1.00 | awaiting T+60 | — | $0.6151 (+38.49%) |
Sep 30, 2026 27d ago | 424B5 | $1.01 | awaiting T+60 | — | $0.6151 (+39.10%) |
Sep 23, 2026 4w ago | 8-K | $1.21 | awaiting T+60 | — | $0.6151 (−49.17%) |
Sep 23, 2026 4w ago | 8-K | $1.39 | awaiting T+60 | — | $0.6151 (−55.75%) |
Aug 14, 2026 10w ago | 8-K | $2.65 | awaiting T+60 | — | $0.6151 (−76.79%) |
Jun 22, 2026 18w ago | EFFECT | $3.88 $1.70 | ▲ +56.19% | ▲ +57.93% | $0.6151 (+84.15%) |
May 15, 2026 23w ago | 8-K | $3.00 $2.66 | ▼ −11.33% | ▼ −16.18% | $0.6151 (−79.50%) |
Showing 10 of 15
US Market Status
Market Open — Closes in 4h 42m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers